Fennec Pharmaceuticals Inc. Common Stock (FENC)
Fennec Pharmaceuticals Inc. Common Stock
XNAS:FENC
8.09
$9.75 - 100.00
$6.96 - 100.00
$7.59
$8.1
$7.67
$7.67
9.92
4.68
151717
260217.2
29609109.9
Chart
TendieTensor AI Analysis
Company
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Fundamentals
32
-33.990000
-50.540400
100
BBG000DTH814
BBG001S69M23
27.91M
27.83M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own FENC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.